Tight control in early RA pays off in the long run-Reference-Cited by-同舟云学术

Tight control in early RA pays off in the long run

Published:2010-10-29 Issue:11 Volume:6 Page:623-624
ISSN:1759-4790
Container-title:Nature Reviews Rheumatology
language:en
Short-container-title:Nat Rev Rheumatol

Author:

Scott David L.,Kowalczyk Anna

Publisher

Springer Science and Business Media LLC

Subject

Rheumatology

Link

http://www.nature.com/articles/nrrheum.2010.174.pdf

Reference10 articles.

1. Rantalaiho, V. et al. Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial. Arthritis Res. Ther. 12, R122 (2010).

2. Möttönen, T. et al. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet 353, 1568–1573 (1999).

3. Scott, D. L., Smith, C. & Kingsley, G. Joint damage and disability in rheumatoid arthritis: an updated systematic review. Clin. Exp. Rheumatol. 21 (5 Suppl. 31), S20–S27 (2003).

4. Deighton, C. et al. Management of rheumatoid arthritis: summary of NICE guidance. BMJ 338, b702 (2009).

5. Smolen, J. S. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann. Rheum. Dis. 69, 964–975 (2010).

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B Lymphocytes in Rheumatoid Arthritis and the Effects of Anti–TNF-α Agents on B Lymphocytes: A Review of the Literature;Clinical Therapeutics;2018-06

2. The clinical effectiveness and cost-effectiveness of treat-to-target strategies in rheumatoid arthritis: a systematic review and cost-effectiveness analysis;Health Technology Assessment;2017-11

3. Defining the proteomic landscape of rheumatoid arthritis: progress and prospective clinical applications;Expert Review of Proteomics;2017-05-02

4. Towards a Stratified Targeted Approach with Biologic Treatments in Rheumatoid Arthritis: Role of Synovial Pathobiology;Current Pharmaceutical Design;2015-04-30

5. Pathogenesis of rheumatoid arthritis: from systemic autoimmunity to localised joint disease;Drug Discovery Today;2014-08